Results 11 to 20 of about 72,471 (294)

Stability of Rifampin in Dimethylsulfoxide [PDF]

Applied Microbiology, 1969
Stock solutions of rifampin remain stable in dimethylsulfoxide for at least 8 months.
John A. Ulrich, Karlson Ag
openaire   +4 more sources

Characterizing complex and competing drug–drug interactions between the antiviral regimen of glecaprevir and pibrentasvir with rifampin or carbamazepine

Clinical and Translational Science, 2023
The fixed‐dose combination of the direct acting antivirals glecaprevir (GLE) and pibrentasvir (PIB) is an oral, once‐daily treatment for all six major genotypes of chronic hepatitis C virus infection.
Matthew P. Kosloski, Hong Li, Stanley Wang, Federico Mensa, Jens Kort, Wei Liu   +5 more
doaj   +1 more source

Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France [PDF]

Journal of Bone and Joint Infection, 2020
Introduction: In patients undergoing a « debridement, antibiotics, and implant retention » (DAIR) procedure for acute staphylococcal prosthetic joint infection (PJI), post-operative treatment with rifampin has been associated with a higher probability of
A. Becker, A. Becker, L. Kreitmann, L. Kreitmann, C. Triffaut-Fillit, C. Triffaut-Fillit, F. Valour, F. Valour, F. Valour, F. Valour, E. Mabrut, E. Forestier, O. Lesens, C. Cazorla, S. Descamps, B. Boyer, C. Chidiac, C. Chidiac, C. Chidiac, S. Lustig, S. Lustig, S. Lustig, E. Montbarbon, C. Batailler, C. Batailler, C. Batailler, T. Ferry, T. Ferry, T. Ferry, T. Ferry   +29 more
doaj   +1 more source

In Vitro Activity of Rifampin, Rifabutin, and Rifapentine against Enterococci and Streptococci from Periprosthetic Joint Infection

Microbiology Spectrum, 2021
After staphylococci, streptococci and enterococci are the most frequent causes of periprosthetic joint infection (PJI). MICs and minimum biofilm bactericidal concentrations of rifampin, rifabutin, and rifapentine were determined for 67 enterococcal and ...
Mariana Albano, Melissa J. Karau, Kerryl E. Greenwood-Quaintance, Douglas R. Osmon, Caitlin P. Oravec, Daniel J. Berry, Matthew P. Abdel, Robin Patel   +7 more
doaj   +1 more source

Structural basis of rifampin inactivation by rifampin phosphotransferase [PDF]

Proceedings of the National Academy of Sciences, 2016
Significance Rifampin phosphotransferases (RPH) belong to a recently identified antibiotic-resistance protein family that inactivates rifampin, the first-line drug against tuberculosis, by phosphorylation. By determining the structures of RPH from Listeria monocytogenes (LmRPH) in different conformations ...
Xiaofeng Qi, Wei Lin, Miaolian Ma, Chengyuan Wang, Yang He, Nisha He, Jing Gao, Hu Zhou, Youli Xiao, Yong Wang, Peng Zhang   +10 more
openaire   +3 more sources

Rifampin-Associated Renal Failure

Annals of Internal Medicine: Clinical Cases, 2023
Rifampin is an effective and widely used for the treatment of both active and latent tuberculosis. Although significant side effects are rare, severe side effects such as acute renal failure have been reported in the literature, usually secondary to ...
Kathleen Miller, Helmut Rennke, Eugene Richardson   +2 more
doaj   +1 more source

Pulmonary aspergilloma: a treatment challenge in sub-saharan Africa. [PDF]

, 2013
Mycobacterium ulcerans infection causes a neglected tropical disease known as Buruli ulcer that is now found in poor rural areas of West Africa in numbers that sometimes exceed those reported for another significant mycobacterial disease, leprosy, caused
AM Baciewicz, AO Soubani, B Dupont, BH Thompson, CA Kauffman, Christian Pohl, Elirehema Mfinanga, Fredrick Haraka, H Grysczyk, JF Regnard, JG Lee, JH Campbell, Joseph M. Vinetz, Khadija Said, KJ Hammerman, Klaus Reither, Levan Jugheli, M Kousha, PC Hopewell, S Kawamura, TJ Walsh   +20 more
core   +5 more sources

Controversy about the Role of Rifampin in Biofilm Infections: Is It Justified?

Antibiotics, 2021
Rifampin is a potent antibiotic against staphylococcal implant-associated infections. In the absence of implants, current data suggest against the use of rifampin combinations.
Nora Renz, Andrej Trampuz, Werner Zimmerli   +2 more
doaj   +1 more source

Prediction of Rivaroxaban-Rifampin Interaction After Major Orthopedic Surgery: Physiologically Based Pharmacokinetic Modeling and Simulation

Frontiers in Pharmacology, 2021
Rivaroxaban is commonly used for the prophylaxis of venous thromboembolism (VTE) for patients undergoing major orthopedic surgery. Rivaroxaban is primarily eliminated by hepatic CYP450 metabolism and renal excretion.
Rui-juan Xu, Rui-juan Xu, Tao Ling, Hong Tang, Wei-hong Ge, Qing Jiang   +5 more
doaj   +1 more source

Comprehensive Management of HIV With Multiple Opportunistic Infections: A Case Report. [PDF]

Clin Case Rep
ABSTRACT Effective management of human immunodeficiency virus patients with multiple opportunistic infections requires a multidisciplinary approach, timely initiation of antiretroviral therapy, and careful adjustment for drug–drug interactions. Coordinated care and vigilant monitoring significantly improve survival and highlight the importance of ...
Boozhmehrani MJ, Hoseinnejad A, Lesani S, Afzalzadeh S, YousefiFard A, Rezaei-Matehkolaei A, Maraghi S, Tavalla M, Taghizadeh Armaki M, Jafarzadeh J, Bastani MN.   +10 more
europepmc   +2 more sources